VALGANCICLOVIR HYDROCHLORIDE POWDER,

VALGANCICLOVIR HYDROCHLORIDE POWDER, was reported 12381 times

VALGANCICLOVIR HYDROCHLORIDE POWDER, is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PSEUDOANEURYSM INFECTION 40 0.7547
1 OESOPHAGOPLEURAL FISTULA 12 0.3750
2 LUNG DISEASE INFECTIVE EXACERBATION 10 0.3704
3 CYTOMEGALOVIRUS SYNDROME 60 0.3636
4 CYTOMEGALOVIRUS NEPHRITIS 18 0.3396
5 CYTOMEGALOVIRUS MYOCARDITIS 11 0.3333
6 PERICARDITIS FUNGAL 19 0.2879
7 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 80 0.2685
8 ENCEPHALITIS CYTOMEGALOVIRUS 114 0.2603
9 PYELONEPHRITIS FUNGAL 17 0.2297
10 IMMUNE RECOVERY UVEITIS 13 0.2241
11 HUMAN EHRLICHIOSIS 43 0.2057
12 GRANULOMATOUS ROSACEA 10 0.2041
13 CHORIOMENINGITIS LYMPHOCYTIC 14 0.2029
14 VASCULAR PSEUDOANEURYSM RUPTURED 44 0.1897
15 CEREBRAL NOCARDIOSIS 40 0.1717
16 GRAFT ISCHAEMIA 8 0.1702
17 CYTOMEGALOVIRUS OESOPHAGITIS 60 0.1630
18 CELL-MEDIATED CYTOTOXICITY 8 0.1569
19 METASTASES TO SALIVARY GLAND 9 0.1525
20 CYTOMEGALOVIRUS DUODENITIS 10 0.1429
21 CUTANEOUS MUCORMYCOSIS 26 0.1413
22 RETROPERITONEAL ABSCESS 17 0.1405
23 CYTOMEGALOVIRUS VIRAEMIA 625 0.1404
24 NEW ONSET DIABETES AFTER TRANSPLANTATION 24 0.1387
25 CUTANEOUS NOCARDIOSIS 18 0.1385
26 DELAYED GRAFT FUNCTION 96 0.1350
27 CYTOMEGALOVIRUS ENTERITIS 45 0.1264
28 DEAFNESS CONGENITAL 25 0.1244
29 CYTOMEGALOVIRUS GASTROENTERITIS 26 0.1204
30 CYTOMEGALOVIRUS GASTRITIS 30 0.1186
31 TRICHOPHYTOSIS 25 0.1179
32 GASTRITIS FUNGAL 12 0.1165
33 SEPTAL PANNICULITIS 9 0.1125
34 SMOOTH MUSCLE CELL NEOPLASM 47 0.1124
35 AUTOIMMUNE PANCYTOPENIA 10 0.1099
36 CHRONIC PAPILLOMATOUS DERMATITIS 8 0.1096
37 RETINITIS VIRAL 13 0.1074
38 CONGENITAL CYTOMEGALOVIRUS INFECTION 18 0.1059
39 RENAL GRAFT INFECTION 24 0.1034
40 TERATOGENICITY 31 0.1026
41 POLYOMAVIRUS VIRAEMIA 106 0.0998
42 PULMONARY NOCARDIOSIS 82 0.0995
43 CYTOMEGALOVIRUS COLITIS 228 0.0990
44 DISSEMINATED CYTOMEGALOVIRAL INFECTION 21 0.0972
45 DRUG RESISTANCE MUTATION 17 0.0955
46 CYTOMEGALOVIRUS INFECTION REACTIVATION 416 0.0941
47 VIRAL UVEITIS 9 0.0928
48 CYTOMEGALOVIRUS CHORIORETINITIS 172 0.0881
49 LUNG TRANSPLANT REJECTION 54 0.0818
50 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 188 0.0802
51 DONOR SPECIFIC ANTIBODY PRESENT 12 0.0779
52 DERMATOPHYTOSIS 22 0.0775
53 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 11 0.0775
54 CYTOMEGALOVIRUS INFECTION 1265 0.0760
55 UREAPLASMA INFECTION 31 0.0760
56 PANCREAS TRANSPLANT REJECTION 15 0.0746
57 MALACOPLAKIA 33 0.0721
58 GRAFT LOSS 52 0.0717
59 PERINEPHRIC COLLECTION 10 0.0699
60 BK VIRUS INFECTION 235 0.0696
61 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 16 0.0690
62 EPSTEIN-BARR VIRAEMIA 76 0.0685
63 PARVOVIRUS B19 INFECTION 61 0.0682
64 CYTOMEGALOVIRUS HEPATITIS 24 0.0678
65 BACILLARY ANGIOMATOSIS 9 0.0662
66 MONKEYPOX 18 0.0652
67 NEUTROPHIL PELGER-HUET ANOMALY PRESENT 12 0.0642
68 HERPES SIMPLEX VIRAEMIA 8 0.0640
69 TRANSPLANT DYSFUNCTION 113 0.0633
70 RENAL TRANSPLANT FAILURE 62 0.0628
71 NOCARDIOSIS 158 0.0617
72 PNEUMONIA CYTOMEGALOVIRAL 118 0.0607
73 TOXOPLASMOSIS 65 0.0602
74 GASTROINTESTINAL MUCORMYCOSIS 10 0.0599
75 LATENT AUTOIMMUNE DIABETES IN ADULTS 10 0.0585
76 TRANSPLANT REJECTION 467 0.0582
77 OESOPHAGEAL ATRESIA 35 0.0560
78 CENTRAL NERVOUS SYSTEM VIRAL INFECTION 8 0.0559
79 SCEDOSPORIUM INFECTION 39 0.0552
80 PENILE ULCERATION 18 0.0550
81 PULMONARY MUCORMYCOSIS 29 0.0549
82 PARVOVIRUS INFECTION 22 0.0545
83 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0543
84 LYMPHOCELE 36 0.0542
85 GRANULOMATOUS DERMATITIS 13 0.0533
86 COMPLICATIONS OF TRANSPLANTED LUNG 16 0.0521
87 DISSEMINATED ASPERGILLOSIS 24 0.0508
88 INFECTION REACTIVATION 58 0.0507
89 GRAFT THROMBOSIS 13 0.0496
90 MUCORMYCOSIS 129 0.0496
91 COMPLICATIONS OF TRANSPLANTED KIDNEY 110 0.0485
92 MYCOTIC ENDOPHTHALMITIS 9 0.0476
93 PROTEUS INFECTION 33 0.0460
94 EYE INFECTION TOXOPLASMAL 18 0.0453
95 KIDNEY TRANSPLANT REJECTION 216 0.0450
96 NEUTROPENIA NEONATAL 10 0.0446
97 INFECTED NEOPLASM 11 0.0442
98 FUNGAL ENDOCARDITIS 13 0.0432
99 ENTEROCOLITIS VIRAL 13 0.0428
100 GLOMERULOSCLEROSIS 27 0.0427
101 STRONGYLOIDIASIS 69 0.0427
102 MENINGITIS FUNGAL 10 0.0426
103 DEHISCENCE 8 0.0423
104 AEROMONAS INFECTION 8 0.0423
105 SCROTAL ULCER 11 0.0421
106 TRICHODYSPLASIA SPINULOSA 16 0.0420
107 HERPES SIMPLEX HEPATITIS 10 0.0417
108 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 135 0.0408
109 INFECTIVE ANEURYSM 20 0.0404
110 MICROSPORIDIA INFECTION 14 0.0399
111 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 63 0.0393
112 CYTOMEGALOVIRUS TEST POSITIVE 70 0.0392
113 BLASTOMYCOSIS 19 0.0391
114 PNEUMOCYSTIS JIROVECII INFECTION 45 0.0377
115 MORGANELLA INFECTION 11 0.0375
116 INTRAOCULAR PRESSURE TEST 9 0.0375
117 CRYPTOCOCCOSIS 61 0.0374
118 CITROBACTER INFECTION 16 0.0373
119 CORONA VIRUS INFECTION 16 0.0372
120 AMERICAN TRYPANOSOMIASIS 10 0.0370
121 DISSEMINATED STRONGYLOIDIASIS 8 0.0365
122 HUMAN HERPESVIRUS 8 INFECTION 22 0.0361
123 CERVICITIS 16 0.0359
124 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 13 0.0358
125 HUMAN HERPESVIRUS 6 ENCEPHALITIS 10 0.0352
126 GLOMERULONEPHROPATHY 9 0.0352
127 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 178 0.0349
128 PATHOGEN RESISTANCE 317 0.0347
129 ADENOVIRAL HEPATITIS 8 0.0340
130 CYSTITIS VIRAL 13 0.0339
131 HUMAN POLYOMAVIRUS INFECTION 18 0.0339
132 EPSTEIN-BARR VIRUS INFECTION 212 0.0339
133 JC VIRUS INFECTION 54 0.0338
134 ENTEROVIRUS INFECTION 29 0.0336
135 DISSEMINATED MUCORMYCOSIS 13 0.0330
136 VIRAEMIA 45 0.0325
137 TOXIC OPTIC NEUROPATHY 14 0.0323
138 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 41 0.0311
139 EYE INFECTION FUNGAL 12 0.0310
140 VIRAL HAEMORRHAGIC CYSTITIS 22 0.0309
141 PERICARDITIS CONSTRICTIVE 13 0.0308
142 ENTEROCOCCAL INFECTION 149 0.0308
143 COLON INJURY 17 0.0296
144 GASTROENTERITIS ESCHERICHIA COLI 16 0.0293
145 ASPERGILLUS TEST POSITIVE 9 0.0292
146 ASPERGILLUS INFECTION 190 0.0289
147 POST PROCEDURAL BILE LEAK 9 0.0288
148 BACTERIURIA 16 0.0283
149 RETINAL SCAR 13 0.0282
150 BRAIN ABSCESS 71 0.0280
151 ARTERIAL HAEMORRHAGE 32 0.0280
152 KLEBSIELLA INFECTION 141 0.0279
153 BRONCHOSTENOSIS 15 0.0274
154 ACINETOBACTER INFECTION 30 0.0274
155 HEPATIC ARTERY THROMBOSIS 8 0.0273
156 ADENOVIRUS INFECTION 78 0.0269
157 CRYPTOSPORIDIOSIS INFECTION 14 0.0267
158 GRAFT INFECTION 9 0.0265
159 DISSEMINATED CRYPTOCOCCOSIS 20 0.0264
160 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 46 0.0260
161 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 31 0.0258
162 CONGENITAL APLASIA 8 0.0257
163 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 9 0.0256
164 RENAL ARTERY STENOSIS 35 0.0254
165 PHAEOHYPHOMYCOSIS 12 0.0251
166 NECROTISING RETINITIS 16 0.0250
167 CYSTITIS HAEMORRHAGIC 100 0.0248
168 PNEUMONIA NECROTISING 16 0.0247
169 ANOREXIA NERVOSA 8 0.0247
170 CEREBRAL TOXOPLASMOSIS 23 0.0246
171 OESOPHAGEAL INFECTION 11 0.0246
172 STENOTROPHOMONAS INFECTION 33 0.0243
173 CORYNEBACTERIUM INFECTION 13 0.0243
174 CARDIAC INFECTION 18 0.0240
175 SUPERINFECTION BACTERIAL 19 0.0240
176 RENAL TUBULAR ATROPHY 21 0.0238
177 BACTERIAL PYELONEPHRITIS 8 0.0238
178 GRAFT VERSUS HOST DISEASE IN SKIN 52 0.0236
179 TRANSPLANT FAILURE 57 0.0232
180 HEART TRANSPLANT REJECTION 24 0.0231
181 ADRENAL MASS 19 0.0229
182 NEUTROPHILIC DERMATOSIS 9 0.0228
183 DRUG RESISTANCE 585 0.0228
184 BLINDNESS CORTICAL 11 0.0224
185 ECTHYMA 9 0.0224
186 CHRONIC ALLOGRAFT NEPHROPATHY 17 0.0217
187 ALTERNARIA INFECTION 8 0.0215
188 FUSARIUM INFECTION 15 0.0214
189 TRANSPLANTATION COMPLICATION 9 0.0214
190 ENCEPHALITIS VIRAL 26 0.0213
191 ANISOCYTOSIS 14 0.0213
192 INFECTION IN AN IMMUNOCOMPROMISED HOST 15 0.0209
193 VASOGENIC CEREBRAL OEDEMA 15 0.0208
194 PERIOSTITIS 9 0.0208
195 KIDNEY FIBROSIS 35 0.0202
196 GASTRIC FISTULA 9 0.0201
197 CAT SCRATCH DISEASE 8 0.0199
198 VARICELLA ZOSTER VIRUS INFECTION 41 0.0198
199 RENAL TUBULAR INJURY 24 0.0198
200 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 42 0.0197
201 CYTOMEGALOVIRUS ENTEROCOLITIS 15 0.0195
202 LIVER TRANSPLANT REJECTION 35 0.0195
203 RENAL VEIN THROMBOSIS 13 0.0192
204 PNEUMONIA CRYPTOCOCCAL 18 0.0190
205 GENITAL LESION 8 0.0188
206 NEPHROPATHY TOXIC 211 0.0188
207 PERIORBITAL CELLULITIS 10 0.0186
208 PNEUMONIA HAEMOPHILUS 9 0.0185
209 PARAINFLUENZAE VIRUS INFECTION 28 0.0184
210 ANAL ULCER 15 0.0184
211 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 133 0.0177
212 ESCHERICHIA INFECTION 143 0.0174
213 BRONCHOPULMONARY ASPERGILLOSIS 134 0.0173
214 THROMBOTIC MICROANGIOPATHY 167 0.0171
215 CHORIORETINITIS 11 0.0171
216 RESPIRATORY TRACT INFECTION FUNGAL 9 0.0170
217 CAMPYLOBACTER GASTROENTERITIS 10 0.0169
218 URINARY TRACT INFECTION PSEUDOMONAL 10 0.0166
219 PNEUMOCYSTIS JIROVECII PNEUMONIA 167 0.0166
220 RENAL ISCHAEMIA 9 0.0165
221 T-LYMPHOCYTE COUNT DECREASED 11 0.0161
222 MENINGITIS VIRAL 22 0.0160
223 KLEBSIELLA SEPSIS 18 0.0160
224 HAEMOLYTIC URAEMIC SYNDROME 37 0.0159
225 SECONDARY IMMUNODEFICIENCY 19 0.0156
226 PNEUMONIA PSEUDOMONAL 24 0.0156
227 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 22 0.0156
228 PNEUMONIA PNEUMOCOCCAL 23 0.0155
229 MEDIASTINITIS 9 0.0155
230 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 13 0.0154
231 MYCOBACTERIUM AVIUM COMPLEX INFECTION 41 0.0153
232 BONE MARROW TOXICITY 18 0.0152
233 PSEUDOMONAS INFECTION 130 0.0151
234 URINARY TRACT INFECTION ENTEROCOCCAL 14 0.0150
235 PNEUMONIA FUNGAL 59 0.0149
236 CEREBRAL ASPERGILLOSIS 9 0.0146
237 OESOPHAGITIS ULCERATIVE 10 0.0146
238 BICYTOPENIA 28 0.0143
239 VIRAL LOAD INCREASED 55 0.0142
240 GENE MUTATION 28 0.0141
241 LEUKOPENIA 704 0.0141
242 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 13 0.0141
243 STEROID DIABETES 21 0.0140
244 MYCOBACTERIUM ABSCESSUS INFECTION 10 0.0140
245 STAPHYLOCOCCAL SKIN INFECTION 17 0.0138
246 LYMPHOPENIA 194 0.0137
247 INTUSSUSCEPTION 13 0.0136
248 ACTINIC KERATOSIS 35 0.0135
249 GRAFT VERSUS HOST DISEASE 96 0.0133
250 BOTULISM 11 0.0133
251 SYSTEMIC CANDIDA 33 0.0131
252 ORCHITIS 14 0.0130
253 NEPHROGENIC DIABETES INSIPIDUS 15 0.0130
254 OBLITERATIVE BRONCHIOLITIS 17 0.0129
255 STREPTOCOCCAL BACTERAEMIA 14 0.0129
256 MYCOPLASMA INFECTION 10 0.0128
257 APLASIA PURE RED CELL 44 0.0128
258 METAPNEUMOVIRUS INFECTION 10 0.0128
259 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 63 0.0126
260 HYPOGAMMAGLOBULINAEMIA 83 0.0126
261 ENTEROBACTER INFECTION 21 0.0125
262 DISSEMINATED TUBERCULOSIS 32 0.0125
263 RHINOVIRUS INFECTION 48 0.0123
264 HAEMOPHILUS INFECTION 12 0.0122
265 HUMAN HERPESVIRUS 6 INFECTION 23 0.0122
266 MENINGITIS CRYPTOCOCCAL 21 0.0120
267 HYPERTENSIVE EMERGENCY 14 0.0119
268 PYELONEPHRITIS ACUTE 23 0.0117
269 PSEUDOMONAL BACTERAEMIA 10 0.0117
270 BACTERIAL SEPSIS 38 0.0117
271 NORMOCHROMIC NORMOCYTIC ANAEMIA 35 0.0116
272 RENAL TUBULAR NECROSIS 114 0.0116
273 CLOSTRIDIUM COLITIS 14 0.0115
274 GLOMERULONEPHRITIS 28 0.0114
275 ESCHERICHIA URINARY TRACT INFECTION 48 0.0113
276 HAEMOPERITONEUM 9 0.0112
277 HYDRONEPHROSIS 84 0.0112
278 HEPATITIS VIRAL 9 0.0112
279 HYPERPLASIA 10 0.0111
280 BRAIN HERNIATION 33 0.0110
281 PNEUMONIA INFLUENZAL 13 0.0109
282 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 12 0.0109
283 CANDIDA INFECTION 179 0.0106
284 VIRAL MUTATION IDENTIFIED 39 0.0106
285 ENTEROCOCCAL BACTERAEMIA 11 0.0104
286 CYTOPENIA 126 0.0103
287 ORGANISING PNEUMONIA 51 0.0103
288 ESCHERICHIA BACTERAEMIA 24 0.0102
289 FUNGAL SKIN INFECTION 41 0.0101
290 DRUG LEVEL FLUCTUATING 9 0.0101
291 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 96 0.0100
292 OESOPHAGEAL CANDIDIASIS 40 0.0100
293 URINARY TRACT INFECTION BACTERIAL 25 0.0099
294 HIRSUTISM 13 0.0098
295 NEUTROPENIC COLITIS 20 0.0097
296 CAMPYLOBACTER INFECTION 8 0.0096
297 SQUAMOUS CELL CARCINOMA OF SKIN 58 0.0096
298 FUNGAEMIA 15 0.0095
299 SYSTEMIC MYCOSIS 11 0.0094
300 ASTERIXIS 10 0.0094
301 ACUTE LUNG INJURY 11 0.0093
302 RETINITIS 16 0.0093
303 GRANULOMA 32 0.0092
304 VASCULAR PSEUDOANEURYSM 16 0.0092
305 RETROPERITONEAL HAEMATOMA 20 0.0090
306 LUNG TRANSPLANT 32 0.0090
307 HYPERURICAEMIA 37 0.0090
308 LARGE INTESTINE INFECTION 11 0.0089
309 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 73 0.0088
310 LARGE INTESTINAL ULCER 24 0.0088
311 PANCYTOPENIA 493 0.0088
312 HERPES SIMPLEX 57 0.0088
313 ACUTE GRAFT VERSUS HOST DISEASE 40 0.0087
314 T-CELL LYMPHOMA 10 0.0087
315 MULTIPLE-DRUG RESISTANCE 27 0.0087
316 ESCHERICHIA SEPSIS 25 0.0086
317 HEPATIC INFECTION 11 0.0086
318 AGRANULOCYTOSIS 160 0.0086
319 HYPERAMMONAEMIA 43 0.0086
320 INFECTIOUS PLEURAL EFFUSION 13 0.0085
321 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
322 BACTERAEMIA 100 0.0084
323 RENAL TRANSPLANT 30 0.0083
324 HYPERPARATHYROIDISM 17 0.0082
325 NEUROLOGICAL DECOMPENSATION 19 0.0082
326 PNEUMONIA KLEBSIELLA 15 0.0082
327 MYCOBACTERIAL INFECTION 14 0.0081
328 CLOSTRIDIUM DIFFICILE COLITIS 86 0.0081
329 INTRA-ABDOMINAL HAEMATOMA 10 0.0081
330 SHOCK HAEMORRHAGIC 64 0.0079
331 STAPHYLOCOCCAL BACTERAEMIA 34 0.0078
332 RENAL TUBULAR DISORDER 22 0.0078
333 RENAL TUBULAR ACIDOSIS 17 0.0078
334 NOSOCOMIAL INFECTION 17 0.0077
335 THROMBOCYTOSIS 28 0.0076
336 CALCIPHYLAXIS 14 0.0076
337 MULTIPLE ORGAN DYSFUNCTION SYNDROME 216 0.0076
338 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 21 0.0076
339 ANAEMIA MACROCYTIC 16 0.0075
340 ODYNOPHAGIA 44 0.0074
341 FIBRIN D DIMER INCREASED 26 0.0073
342 BILIARY TRACT DISORDER 10 0.0072
343 VENOOCCLUSIVE LIVER DISEASE 35 0.0071
344 MENINGITIS BACTERIAL 10 0.0070
345 NOROVIRUS INFECTION 10 0.0069
346 PYELONEPHRITIS 60 0.0069
347 SEPTIC SHOCK 299 0.0069
348 VENOOCCLUSIVE DISEASE 17 0.0068
349 ABDOMINAL ABSCESS 30 0.0068
350 GASTROINTESTINAL ULCER 15 0.0068
351 OESOPHAGEAL ULCER 26 0.0068
352 PSEUDOMEMBRANOUS COLITIS 15 0.0067
353 WOUND COMPLICATION 23 0.0067
354 CHRONIC GRAFT VERSUS HOST DISEASE 24 0.0066
355 MIXED LIVER INJURY 20 0.0066
356 HAEMATOLOGICAL INFECTION 16 0.0065
357 RESPIRATORY TRACT INFECTION VIRAL 15 0.0064
358 NEUTROPENIA 874 0.0064
359 INFECTED SKIN ULCER 12 0.0063
360 PULMONARY SEPSIS 9 0.0062
361 NORMOCYTIC ANAEMIA 9 0.0061
362 GASTROENTERITIS NOROVIRUS 8 0.0060
363 GASTROINTESTINAL STROMAL TUMOUR 16 0.0060
364 HYPERPARATHYROIDISM SECONDARY 15 0.0060
365 BONE MARROW FAILURE 119 0.0058
366 HEPATITIS E 9 0.0057
367 LUNG OPACITY 15 0.0057
368 DRUG LEVEL ABOVE THERAPEUTIC 26 0.0057
369 THROMBOTIC THROMBOCYTOPENIC PURPURA 20 0.0057
370 HYPERVOLAEMIA 28 0.0057
371 ATYPICAL MYCOBACTERIAL INFECTION 8 0.0057
372 ENDOCARDITIS 29 0.0056
373 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 15 0.0056
374 MYELOSUPPRESSION 203 0.0056
375 INTRAVENTRICULAR HAEMORRHAGE 14 0.0056
376 LIVER ABSCESS 18 0.0055
377 LIVER TRANSPLANT 20 0.0055
378 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 12 0.0055
379 CHOLESTATIC LIVER INJURY 12 0.0054
380 PNEUMONIA BACTERIAL 49 0.0053
381 SALMONELLOSIS 9 0.0053
382 POST PROCEDURAL HAEMATOMA 9 0.0053
383 SMALL INTESTINAL PERFORATION 10 0.0053
384 PNEUMONIA VIRAL 17 0.0053
385 STUPOR 17 0.0053
386 HYPOPHOSPHATAEMIA 39 0.0053
387 HYPOPROTEINAEMIA 10 0.0053
388 FIXED ERUPTION 9 0.0052
389 DRUG LEVEL INCREASED 86 0.0052
390 APLASTIC ANAEMIA 27 0.0052
391 GUILLAIN-BARRE SYNDROME 25 0.0052
392 COVID-19 PNEUMONIA 61 0.0052
393 PULMONARY TUBERCULOSIS 22 0.0051
394 OESOPHAGEAL STENOSIS 14 0.0049
395 LEFT VENTRICULAR HYPERTROPHY 21 0.0049
396 BACTERIAL INFECTION 91 0.0049
397 CHRONIC GASTRITIS 11 0.0049
398 ACUTE RESPIRATORY DISTRESS SYNDROME 86 0.0049
399 HYPERCALCAEMIA 60 0.0049
400 CAPILLARY LEAK SYNDROME 10 0.0048
401 RENAL IMPAIRMENT 406 0.0048
402 DIFFUSE LARGE B-CELL LYMPHOMA 37 0.0048
403 VITREOUS HAEMORRHAGE 13 0.0047
404 HAEMATOTOXICITY 44 0.0046
405 ADRENOCORTICAL INSUFFICIENCY ACUTE 9 0.0046
406 SUBCUTANEOUS ABSCESS 22 0.0046
407 GASTRIC PERFORATION 12 0.0044
408 DENGUE FEVER 10 0.0044
409 HAEMOLYTIC ANAEMIA 39 0.0043
410 TUBULOINTERSTITIAL NEPHRITIS 81 0.0043
411 METHAEMOGLOBINAEMIA 10 0.0043
412 BLADDER SPASM 8 0.0043
413 STAPHYLOCOCCAL SEPSIS 21 0.0042
414 HEPATIC NECROSIS 16 0.0042
415 OTITIS MEDIA 14 0.0042
416 DUODENITIS 13 0.0042
417 FEBRILE BONE MARROW APLASIA 18 0.0042
418 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 43 0.0042
419 CYTOKINE RELEASE SYNDROME 84 0.0042
420 THROMBOCYTOPENIA 465 0.0042
421 ENTEROCOLITIS 24 0.0042
422 ACUTE KIDNEY INJURY 633 0.0041
423 GENERALISED OEDEMA 51 0.0041
424 PARESIS 9 0.0040
425 END STAGE RENAL DISEASE 73 0.0040
426 PRE-ECLAMPSIA 19 0.0040
427 LUNG ADENOCARCINOMA 12 0.0040
428 HYPERCAPNIA 12 0.0040
429 HIV INFECTION 12 0.0040
430 GASTROINTESTINAL TOXICITY 19 0.0040
431 ORAL CANDIDIASIS 52 0.0039
432 SERUM SICKNESS 11 0.0039
433 RESPIRATORY FAILURE 285 0.0039
434 ENCEPHALITIS 27 0.0039
435 FUNGAL INFECTION 130 0.0039
436 NEPHROGENIC ANAEMIA 18 0.0039
437 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
438 OLIGURIA 24 0.0039
439 LUNG INFILTRATION 34 0.0038
440 PULMONARY ALVEOLAR HAEMORRHAGE 21 0.0037
441 RESPIRATORY DISTRESS 103 0.0037
442 BRAIN OEDEMA 47 0.0037
443 ENCEPHALOPATHY 91 0.0037
444 UROSEPSIS 34 0.0037
445 ATYPICAL PNEUMONIA 11 0.0037
446 HYDROCEPHALUS 20 0.0037
447 THYROIDITIS 11 0.0037
448 HYPOMAGNESAEMIA 51 0.0037
449 ONYCHOMYCOSIS 16 0.0036
450 CLOSTRIDIUM TEST POSITIVE 8 0.0036
451 PROSTATITIS 11 0.0036
452 STAPHYLOCOCCAL INFECTION 119 0.0036
453 FEBRILE NEUTROPENIA 238 0.0036
454 WOUND DEHISCENCE 12 0.0035
455 URINE OUTPUT DECREASED 31 0.0035
456 IMMUNE THROMBOCYTOPENIA 16 0.0035
457 BUNDLE BRANCH BLOCK RIGHT 16 0.0035
458 HYPERKALAEMIA 122 0.0035
459 BLOOD CREATININE INCREASED 223 0.0034
460 HYPERBILIRUBINAEMIA 35 0.0034
461 SPLENOMEGALY 39 0.0033
462 NEPHROPATHY 31 0.0033
463 SUBDURAL HAEMORRHAGE 9 0.0033
464 POSTOPERATIVE WOUND INFECTION 22 0.0033
465 COLITIS 123 0.0032
466 PORTAL HYPERTENSION 10 0.0032
467 ORGAN FAILURE 13 0.0032
468 CARDIAC DYSFUNCTION 12 0.0032
469 LUNG CONSOLIDATION 9 0.0032
470 HEPATOCELLULAR INJURY 45 0.0032
471 PNEUMATOSIS INTESTINALIS 9 0.0032
472 HEPATITIS CHOLESTATIC 19 0.0032
473 HAEMODYNAMIC INSTABILITY 24 0.0031
474 HEPATOSPLENOMEGALY 8 0.0031
475 AORTIC ARTERIOSCLEROSIS 8 0.0031
476 HAEMOTHORAX 9 0.0031
477 SKIN NECROSIS 16 0.0031
478 CHOLESTASIS 59 0.0031
479 ABSCESS LIMB 13 0.0030
480 SEPSIS 340 0.0030
481 PLEURISY 18 0.0030
482 CLOSTRIDIUM DIFFICILE INFECTION 66 0.0030
483 ACUTE RESPIRATORY FAILURE 58 0.0030
484 MYOPATHY 26 0.0030
485 AMYLASE INCREASED 11 0.0030
486 FOETAL GROWTH RESTRICTION 18 0.0030
487 B-CELL LYMPHOMA 10 0.0029
488 MENINGITIS ASEPTIC 13 0.0029
489 ASCITES 85 0.0029
490 DIARRHOEA HAEMORRHAGIC 27 0.0029
491 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 11 0.0029
492 NECROSIS 16 0.0029
493 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
494 PNEUMOTHORAX 45 0.0028
495 IMMUNOSUPPRESSION 25 0.0028
496 RETINAL DETACHMENT 26 0.0028
497 HYPERNATRAEMIA 14 0.0028
498 NEUROLOGICAL SYMPTOM 16 0.0028
499 SHOCK 64 0.0028
500 MALNUTRITION 31 0.0028
501 ABSCESS 44 0.0028
502 ELECTROLYTE IMBALANCE 32 0.0028
503 DEAFNESS NEUROSENSORY 9 0.0027
504 APHTHOUS ULCER 21 0.0027
505 INTRACRANIAL PRESSURE INCREASED 15 0.0027
506 NEUROTOXICITY 47 0.0027
507 METASTASES TO SPINE 9 0.0027
508 SUSPECTED OFF LABEL USE 12 0.0027
509 PROTEINURIA 50 0.0026
510 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
511 ACIDOSIS 20 0.0026
512 HEPATITIS 66 0.0026
513 HYPOVOLAEMIA 15 0.0026
514 HYPERTRIGLYCERIDAEMIA 15 0.0026
515 ANURIA 22 0.0026
516 SUBARACHNOID HAEMORRHAGE 26 0.0026
517 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
518 GASTRIC ULCER 48 0.0025
519 LOW BIRTH WEIGHT BABY 20 0.0025
520 MYOCLONUS 30 0.0025
521 ENDOPHTHALMITIS 15 0.0025
522 SKIN PAPILLOMA 10 0.0025
523 TONSILLITIS 13 0.0025
524 BLOOD CREATINE INCREASED 11 0.0025
525 PULMONARY MASS 37 0.0025
526 METABOLIC ACIDOSIS 79 0.0025
527 ORAL DISORDER 18 0.0025
528 MENTAL STATUS CHANGES 68 0.0024
529 LARGE INTESTINE PERFORATION 17 0.0024
530 HEPATOMEGALY 24 0.0024
531 PNEUMONITIS 66 0.0024
532 ABDOMINAL TENDERNESS 12 0.0024
533 RASH MACULO-PAPULAR 53 0.0024
534 LEUKOCYTOSIS 43 0.0024
535 BASAL CELL CARCINOMA 37 0.0024
536 DYSLIPIDAEMIA 12 0.0024
537 DRUG LEVEL DECREASED 24 0.0024
538 DRUG LEVEL BELOW THERAPEUTIC 13 0.0024
539 DIABETIC RETINOPATHY 8 0.0024
540 ANAEMIA 447 0.0023
541 ACUTE HEPATIC FAILURE 32 0.0023
542 HEPATIC LESION 10 0.0023
543 OFF LABEL USE 2019 0.0023
544 GASTROENTERITIS 33 0.0023
545 FACIAL PARESIS 8 0.0023
546 HEPATOTOXICITY 50 0.0022
547 TERMINAL STATE 15 0.0022
548 INFUSION SITE SWELLING 14 0.0022
549 EXTRAVASATION 9 0.0022
550 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
551 STATUS EPILEPTICUS 24 0.0021
552 WOUND INFECTION 23 0.0021
553 LEFT VENTRICULAR DYSFUNCTION 14 0.0021
554 MOUTH ULCERATION 44 0.0021
555 POLYURIA 17 0.0021
556 ADRENAL INSUFFICIENCY 25 0.0021
557 DIVERTICULUM INTESTINAL 9 0.0021
558 PULMONARY FUNCTION TEST DECREASED 9 0.0021
559 PLEURAL EFFUSION 125 0.0021
560 PERIPHERAL SENSORY NEUROPATHY 12 0.0021
561 HYPOXIA 72 0.0020
562 HEPATIC CYTOLYSIS 26 0.0020
563 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
564 C-REACTIVE PROTEIN INCREASED 74 0.0020
565 LIVE BIRTH 17 0.0020
566 MULTI-ORGAN FAILURE 35 0.0020
567 CARDIOGENIC SHOCK 29 0.0020
568 LEUKAEMIA 19 0.0020
569 DISSEMINATED INTRAVASCULAR COAGULATION 28 0.0020
570 OSTEOMYELITIS 36 0.0020
571 TOXIC ENCEPHALOPATHY 10 0.0020
572 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 108 0.0020
573 RETINAL HAEMORRHAGE 14 0.0020
574 PHLEBITIS 10 0.0020
575 PRODUCT USE IN UNAPPROVED INDICATION 484 0.0020
576 HEMIPARESIS 33 0.0019
577 CACHEXIA 10 0.0019
578 GASTRITIS EROSIVE 9 0.0019
579 MYOCARDITIS 22 0.0019
580 DRUG INTERACTION 304 0.0019
581 MALABSORPTION 10 0.0019
582 FACIAL PARALYSIS 16 0.0019
583 LARGE INTESTINE POLYP 13 0.0019
584 HAEMORRHAGE INTRACRANIAL 28 0.0019
585 HYPERTRANSAMINASAEMIA 13 0.0019
586 AUTOIMMUNE HEPATITIS 13 0.0019
587 FOOD POISONING 10 0.0019
588 TOXIC EPIDERMAL NECROLYSIS 28 0.0018
589 HEPATITIS B 11 0.0018
590 INTENTIONAL PRODUCT USE ISSUE 159 0.0018
591 HYPONATRAEMIA 102 0.0018
592 COAGULOPATHY 30 0.0018
593 VISUAL FIELD DEFECT 13 0.0018
594 MUCOSAL INFLAMMATION 47 0.0018
595 BRONCHIECTASIS 12 0.0018
596 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
597 HAEMATURIA 60 0.0018
598 NEPHROTIC SYNDROME 12 0.0017
599 FOLLICULITIS 18 0.0017
600 ILEUS 21 0.0017
601 HEMIPLEGIA 14 0.0017
602 TRANSAMINASES INCREASED 37 0.0017
603 PULMONARY HAEMORRHAGE 13 0.0017
604 HEPATITIS C 20 0.0017
605 PYREXIA 573 0.0017
606 SMALL INTESTINAL OBSTRUCTION 20 0.0016
607 GENERAL PHYSICAL CONDITION ABNORMAL 11 0.0016
608 TACHYPNOEA 22 0.0016
609 RESPIRATORY SYNCYTIAL VIRUS INFECTION 14 0.0016
610 HEPATIC ENZYME ABNORMAL 8 0.0016
611 CENTRAL NERVOUS SYSTEM LESION 22 0.0016
612 FLANK PAIN 15 0.0016
613 TUMOUR LYSIS SYNDROME 14 0.0016
614 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 8 0.0016
615 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
616 RENAL FAILURE 208 0.0016
617 HALLUCINATION, VISUAL 33 0.0016
618 RALES 9 0.0015
619 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
620 INTERSTITIAL LUNG DISEASE 75 0.0015
621 UVEITIS 21 0.0015
622 SKIN ULCER 40 0.0015
623 HYPOALBUMINAEMIA 12 0.0015
624 INFUSION SITE ERYTHEMA 13 0.0015
625 AUTOIMMUNE DISORDER 15 0.0015
626 HAEMATEMESIS 39 0.0015
627 LYMPHADENOPATHY 54 0.0015
628 PNEUMONIA ASPIRATION 38 0.0015
629 INTESTINAL PERFORATION 17 0.0015
630 TRICUSPID VALVE INCOMPETENCE 12 0.0015
631 URINARY TRACT INFECTION 256 0.0015
632 PREMATURE BABY 45 0.0015
633 DEVICE RELATED INFECTION 23 0.0015
634 GASTRITIS 39 0.0015
635 HYPERGLYCAEMIA 54 0.0015
636 LIVER FUNCTION TEST ABNORMAL 43 0.0015
637 LYMPHOCYTE COUNT DECREASED 26 0.0015
638 TOXICITY TO VARIOUS AGENTS 244 0.0014
639 PREMATURE DELIVERY 23 0.0014
640 FLUID OVERLOAD 21 0.0014
641 HEPATIC FAILURE 43 0.0014
642 HYPERLIPIDAEMIA 17 0.0014
643 PULMONARY FIBROSIS 27 0.0014
644 ARTERIOSCLEROSIS 13 0.0014
645 POLYP 9 0.0014
646 UPPER GASTROINTESTINAL HAEMORRHAGE 23 0.0014
647 LUNG DISORDER 67 0.0014
648 DIABETES MELLITUS 103 0.0013
649 HAEMATOMA 35 0.0013
650 SKIN MASS 9 0.0013
651 MENINGITIS 9 0.0013
652 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
653 THERAPY NON-RESPONDER 60 0.0013
654 ABNORMAL LOSS OF WEIGHT 9 0.0013
655 HEPATOCELLULAR CARCINOMA 10 0.0013
656 HYPERTHERMIA 10 0.0013
657 LIVER INJURY 32 0.0013
658 PULMONARY OEDEMA 58 0.0013
659 PERITONITIS BACTERIAL 13 0.0013
660 LUNG INFECTION 20 0.0013
661 BLOOD MAGNESIUM DECREASED 11 0.0013
662 DIVERTICULUM 9 0.0013
663 NEUTROPENIC SEPSIS 9 0.0013
664 ULCER 20 0.0013
665 ENTERITIS 8 0.0012
666 SKIN LESION 34 0.0012
667 DEPRESSED LEVEL OF CONSCIOUSNESS 49 0.0012
668 SCHIZOPHRENIA 15 0.0012
669 INFECTION 178 0.0012
670 ORAL HERPES 24 0.0012
671 RESPIRATORY TRACT INFECTION 32 0.0012
672 GAMMA-GLUTAMYLTRANSFERASE INCREASED 27 0.0012
673 DIABETIC KETOACIDOSIS 29 0.0012
674 OESOPHAGITIS 13 0.0012
675 COLITIS ULCERATIVE 53 0.0012
676 VIRAL INFECTION 39 0.0012
677 LYMPHOMA 18 0.0012
678 TREATMENT FAILURE 96 0.0012
679 HAEMOGLOBIN DECREASED 117 0.0011
680 ATELECTASIS 11 0.0011
681 COVID-19 199 0.0011
682 DUODENAL ULCER 8 0.0011
683 NEUTROPHIL COUNT DECREASED 46 0.0011
684 PERICARDIAL EFFUSION 26 0.0011
685 PNEUMONIA 362 0.0011
686 DISEASE RECURRENCE 53 0.0011
687 DYSURIA 41 0.0011
688 ASPIRATION 12 0.0011
689 INFLAMMATION 56 0.0011
690 EMBOLISM 9 0.0011
691 DRUG-INDUCED LIVER INJURY 34 0.0011
692 KIDNEY INFECTION 21 0.0011
693 PANCREATITIS ACUTE 24 0.0011
694 PERITONITIS 22 0.0011
695 MITRAL VALVE INCOMPETENCE 12 0.0011
696 FOETAL EXPOSURE DURING PREGNANCY 86 0.0011
697 SINUS TACHYCARDIA 15 0.0011
698 HYPOPHAGIA 27 0.0011
699 CHRONIC KIDNEY DISEASE 80 0.0011
700 HAEMOLYSIS 8 0.0010
701 ACUTE MYELOID LEUKAEMIA 16 0.0010
702 CARDIOMYOPATHY 15 0.0010
703 GASTROINTESTINAL INFECTION 9 0.0010
704 MYOSITIS 9 0.0010
705 GASTROINTESTINAL DISORDER 88 0.0010
706 CARDIAC ARREST 81 0.0010
707 FISTULA 11 0.0010
708 OEDEMA 53 0.0010
709 IMPAIRED HEALING 32 0.0010
710 REBOUND EFFECT 11 0.0010
711 HELICOBACTER INFECTION 10 0.0010
712 THERAPY PARTIAL RESPONDER 15 0.0010
713 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
714 PETECHIAE 10 0.0010
715 PRODUCT USE ISSUE 180 0.0010
716 BLINDNESS 39 0.0010
717 PERICARDITIS 16 0.0010
718 ACUTE MYOCARDIAL INFARCTION 28 0.0009
719 HYPOTENSION 190 0.0009
720 IMMUNODEFICIENCY 14 0.0009
721 HEPATIC FUNCTION ABNORMAL 35 0.0009
722 BLOOD POTASSIUM INCREASED 15 0.0009
723 DRUG INEFFECTIVE 1198 0.0009
724 DRUG ERUPTION 16 0.0009
725 BLOOD UREA INCREASED 15 0.0009
726 SKIN INFECTION 10 0.0009
727 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
728 ABDOMINAL PAIN 204 0.0009
729 RENAL FAILURE ACUTE 37 0.0009
730 WHITE BLOOD CELL COUNT DECREASED 94 0.0009
731 DIARRHOEA 556 0.0009
732 APHASIA 26 0.0009
733 TREATMENT NONCOMPLIANCE 47 0.0009
734 LOWER RESPIRATORY TRACT INFECTION 39 0.0009
735 HERPES ZOSTER 49 0.0009
736 BLINDNESS UNILATERAL 12 0.0008
737 ATRIAL FIBRILLATION 82 0.0008
738 RENAL INJURY 25 0.0008
739 CONDITION AGGRAVATED 255 0.0008
740 TREMOR 138 0.0008
741 PULMONARY EMBOLISM 79 0.0008
742 OEDEMA PERIPHERAL 101 0.0008
743 UPPER RESPIRATORY TRACT INFECTION 38 0.0008
744 PRODUCTIVE COUGH 39 0.0008
745 RENAL DISORDER 38 0.0008
746 URINARY RETENTION 27 0.0008
747 CONJUNCTIVITIS 15 0.0008
748 IMPAIRED GASTRIC EMPTYING 11 0.0008
749 DELIRIUM 28 0.0008
750 EOSINOPHILIA 14 0.0008
751 LIVER FUNCTION TEST INCREASED 17 0.0008
752 OSTEONECROSIS 26 0.0008
753 VENTRICULAR TACHYCARDIA 13 0.0008
754 MASS 11 0.0008
755 DEEP VEIN THROMBOSIS 51 0.0008
756 HYPOKALAEMIA 36 0.0008
757 METASTASES TO LUNG 9 0.0008
758 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0008
759 PARALYSIS 11 0.0008
760 NODULE 10 0.0008
761 MYELODYSPLASTIC SYNDROME 11 0.0008
762 CHOLECYSTITIS 9 0.0008
763 TACHYCARDIA 67 0.0008
764 HAEMOPTYSIS 21 0.0008
765 PRESCRIBED UNDERDOSE 15 0.0008
766 HEPATIC STEATOSIS 14 0.0008
767 ABDOMINAL PAIN LOWER 19 0.0008
768 PRESYNCOPE 18 0.0007
769 COMA 35 0.0007
770 ALANINE AMINOTRANSFERASE INCREASED 45 0.0007
771 DISORIENTATION 29 0.0007
772 BLOOD COUNT ABNORMAL 11 0.0007
773 CARDIO-RESPIRATORY ARREST 30 0.0007
774 MYDRIASIS 9 0.0007
775 BRONCHOSPASM 10 0.0007
776 SUBDURAL HAEMATOMA 10 0.0007
777 DISEASE PROGRESSION 82 0.0007
778 LACTIC ACIDOSIS 22 0.0007
779 HYPERTENSION 143 0.0007
780 CELLULITIS 34 0.0007
781 ORAL PAIN 15 0.0007
782 BLOOD PRESSURE FLUCTUATION 16 0.0007
783 PLATELET COUNT DECREASED 71 0.0007
784 BRADYCARDIA 35 0.0007
785 NEURALGIA 16 0.0007
786 NO ADVERSE EVENT 118 0.0007
787 RHABDOMYOLYSIS 27 0.0006
788 CEREBRAL HAEMORRHAGE 23 0.0006
789 NERVOUS SYSTEM DISORDER 20 0.0006
790 SKIN REACTION 9 0.0006
791 GASTROINTESTINAL HAEMORRHAGE 52 0.0006
792 DECREASED APPETITE 143 0.0006
793 HAEMORRHOIDS 12 0.0006
794 DEAFNESS 16 0.0006
795 PHOTOSENSITIVITY REACTION 10 0.0006
796 RESTLESS LEGS SYNDROME 11 0.0006
797 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
798 TYPE 2 DIABETES MELLITUS 20 0.0006
799 CONFUSIONAL STATE 96 0.0006
800 BLOOD BILIRUBIN INCREASED 16 0.0006
801 FLUID RETENTION 30 0.0006
802 WEIGHT DECREASED 164 0.0006
803 LIVER DISORDER 26 0.0006
804 DEHYDRATION 78 0.0006
805 DYSPNOEA EXERTIONAL 22 0.0006
806 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 17 0.0006
807 EXPOSURE DURING PREGNANCY 36 0.0006
808 ORTHOSTATIC HYPOTENSION 10 0.0006
809 CARDIAC FAILURE 46 0.0006
810 CEREBRAL INFARCTION 14 0.0006
811 CHILLS 67 0.0006
812 DIALYSIS 8 0.0006
813 COUGH 158 0.0006
814 RED BLOOD CELL COUNT DECREASED 16 0.0006
815 APATHY 8 0.0005
816 MELAENA 12 0.0005
817 BODY TEMPERATURE INCREASED 11 0.0005
818 LETHARGY 31 0.0005
819 HEPATIC CIRRHOSIS 10 0.0005
820 PULMONARY HYPERTENSION 11 0.0005
821 HAEMATOCHEZIA 29 0.0005
822 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
823 THROMBOSIS 42 0.0005
824 OXYGEN SATURATION DECREASED 29 0.0005
825 DELUSION 8 0.0005
826 SKIN CANCER 11 0.0005
827 DRUG INTOLERANCE 49 0.0005
828 PRODUCT PRESCRIBING ERROR 12 0.0005
829 GOUT 9 0.0005
830 GENERAL PHYSICAL HEALTH DETERIORATION 58 0.0005
831 DIPLOPIA 13 0.0005
832 GASTROENTERITIS VIRAL 9 0.0005
833 VOMITING 234 0.0005
834 FULL BLOOD COUNT DECREASED 10 0.0005
835 THERAPY CESSATION 25 0.0005
836 DYSPHAGIA 46 0.0005
837 JAUNDICE 13 0.0005
838 MATERNAL EXPOSURE DURING PREGNANCY 43 0.0005
839 PHOTOPHOBIA 9 0.0005
840 HYPOCALCAEMIA 9 0.0005
841 CYSTITIS 15 0.0005
842 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
843 CIRCULATORY COLLAPSE 8 0.0005
844 SEROTONIN SYNDROME 9 0.0005
845 PRESCRIBED OVERDOSE 9 0.0005
846 FAECES DISCOLOURED 10 0.0005
847 BRONCHITIS 34 0.0005
848 PANCREATITIS 24 0.0005
849 ABDOMINAL DISTENSION 47 0.0004
850 HAEMORRHAGE 47 0.0004
851 PALLOR 12 0.0004
852 PSYCHOTIC DISORDER 13 0.0004
853 INFLUENZA 49 0.0004
854 RESPIRATORY DISORDER 13 0.0004
855 CHOLELITHIASIS 14 0.0004
856 ASTHENIA 160 0.0004
857 HEPATIC ENZYME INCREASED 29 0.0004
858 RETCHING 9 0.0004
859 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 30 0.0004
860 NEUROPATHY PERIPHERAL 40 0.0004
861 ANHEDONIA 11 0.0004
862 HYPOACUSIS 18 0.0004
863 PRODUCT PRESCRIBING ISSUE 9 0.0004
864 GASTRIC DISORDER 14 0.0004
865 NIGHT SWEATS 13 0.0004
866 HAEMATOCRIT DECREASED 8 0.0004
867 VISUAL IMPAIRMENT 49 0.0004
868 OVERDOSE 85 0.0004
869 SINUSITIS 40 0.0004
870 UNRESPONSIVE TO STIMULI 10 0.0004
871 COGNITIVE DISORDER 18 0.0004
872 ACCIDENTAL OVERDOSE 14 0.0004
873 SEIZURE 44 0.0004
874 LOCALISED INFECTION 9 0.0004
875 FREQUENT BOWEL MOVEMENTS 10 0.0004
876 OSTEOPOROSIS 15 0.0004
877 OSTEONECROSIS OF JAW 9 0.0004
878 DYSPNOEA 203 0.0004
879 RASH ERYTHEMATOUS 17 0.0004
880 CHROMATURIA 8 0.0004
881 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
882 RECTAL HAEMORRHAGE 15 0.0003
883 NEOPLASM PROGRESSION 12 0.0003
884 NAUSEA 268 0.0003
885 EAR INFECTION 9 0.0003
886 DEATH 289 0.0003
887 AGITATION 24 0.0003
888 CATARACT 19 0.0003
889 CEREBROVASCULAR ACCIDENT 54 0.0003
890 ARRHYTHMIA 15 0.0003
891 UNDERDOSE 23 0.0003
892 RASH PRURITIC 17 0.0003
893 STOMATITIS 19 0.0003
894 CHEST PAIN 57 0.0003
895 PLASMA CELL MYELOMA 12 0.0003
896 OROPHARYNGEAL PAIN 28 0.0003
897 INFUSION RELATED REACTION 20 0.0003
898 BLOOD POTASSIUM DECREASED 9 0.0003
899 MENTAL DISORDER 13 0.0003
900 HOSPITALISATION 45 0.0003
901 ILLNESS 30 0.0003
902 DIVERTICULITIS 8 0.0003
903 HYPOGLYCAEMIA 14 0.0003
904 BLISTER 16 0.0003
905 HYPOTHYROIDISM 9 0.0003
906 VERTIGO 17 0.0003
907 GASTROOESOPHAGEAL REFLUX DISEASE 22 0.0003
908 CONSTIPATION 59 0.0003
909 RASH 117 0.0003
910 EPISTAXIS 20 0.0003
911 INFLUENZA LIKE ILLNESS 22 0.0003
912 DYSARTHRIA 10 0.0003
913 RHINORRHOEA 17 0.0003
914 EPILEPSY 8 0.0003
915 TINNITUS 12 0.0003
916 ABNORMAL BEHAVIOUR 10 0.0003
917 HEADACHE 157 0.0003
918 ERYTHEMA 51 0.0002
919 HALLUCINATION 18 0.0002
920 ANAPHYLACTIC REACTION 13 0.0002
921 ABDOMINAL PAIN UPPER 48 0.0002
922 DYSGEUSIA 17 0.0002
923 MALAISE 99 0.0002
924 ABORTION SPONTANEOUS 9 0.0002
925 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
926 SWELLING 21 0.0002
927 FATIGUE 168 0.0002
928 SWELLING FACE 14 0.0002
929 DYSPEPSIA 21 0.0002
930 MYALGIA 36 0.0002
931 MUSCULOSKELETAL PAIN 11 0.0002
932 NEOPLASM MALIGNANT 14 0.0002
933 BLOOD PRESSURE INCREASED 32 0.0002
934 INTENTIONAL PRODUCT MISUSE 18 0.0002
935 LOSS OF CONSCIOUSNESS 26 0.0002
936 THERAPEUTIC RESPONSE DECREASED 12 0.0002
937 ILL-DEFINED DISORDER 12 0.0002
938 DISCOMFORT 12 0.0002
939 PRURITUS 75 0.0002
940 EYE PAIN 11 0.0002
941 VISION BLURRED 26 0.0002
942 PALPITATIONS 22 0.0002
943 BACK PAIN 43 0.0002
944 WEIGHT INCREASED 41 0.0002
945 SYNCOPE 18 0.0002
946 EMOTIONAL DISTRESS 21 0.0002
947 ABDOMINAL DISCOMFORT 29 0.0002
948 BLOOD CHOLESTEROL INCREASED 8 0.0002
949 HEART RATE INCREASED 17 0.0002
950 NASAL CONGESTION 10 0.0002
951 PERIPHERAL SWELLING 26 0.0002
952 IRRITABILITY 10 0.0002
953 SKIN EXFOLIATION 14 0.0002
954 HYPERHIDROSIS 21 0.0002
955 HYPOAESTHESIA 24 0.0002
956 DEPRESSION 36 0.0002
957 AMNESIA 10 0.0002
958 MUSCULAR WEAKNESS 17 0.0001
959 CARDIAC FAILURE CONGESTIVE 12 0.0001
960 CHEST DISCOMFORT 15 0.0001
961 GAIT DISTURBANCE 28 0.0001
962 MEMORY IMPAIRMENT 20 0.0001
963 SOMNOLENCE 29 0.0001
964 FALL 47 0.0001
965 ADVERSE EVENT 13 0.0001
966 JOINT SWELLING 17 0.0001
967 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25 0.0001
968 INSOMNIA 36 0.0001
969 ANXIETY 38 0.0001
970 PARAESTHESIA 21 0.0001
971 UNEVALUABLE EVENT 10 0.0001
972 PAIN 81 0.0001
973 SUICIDAL IDEATION 12 0.0001
974 DIZZINESS 65 0.0001
975 ARTHRALGIA 54 0.0001
976 ALOPECIA 25 0.0001
977 MUSCULOSKELETAL STIFFNESS 11 0.0001
978 CONTUSION 12 0.0001
979 HYPERSENSITIVITY 23 0.0001
980 PAIN IN EXTREMITY 36 0.0001
981 BLOOD PRESSURE DECREASED 8 0.0001
982 DRY SKIN 16 0.0001
983 INCORRECT DOSE ADMINISTERED 27 0.0001
984 NASOPHARYNGITIS 20 0.0001
985 CARDIAC DISORDER 10 0.0001
986 URTICARIA 17 0.0001
987 BALANCE DISORDER 8 0.0001
988 PRODUCT DOSE OMISSION ISSUE 24 0.0001
989 DRUG DOSE OMISSION 13 0.0001
990 MYOCARDIAL INFARCTION 13 0.0001
991 MUSCLE SPASMS 12 0.0001
992 BLOOD GLUCOSE INCREASED 11 0.0001
993 FEELING ABNORMAL 11 0.0000